Leading manufacturers appeal in proceedings against discriminatory wastewater fees on medicine before European Court of Justice

Gemme is transforming and becoming ALMA – Alliance des Médicaments Abordables

Open Letter on Critical Medicines Act trilogues negotations – The CMA must deliver on EU health security

New EU Pharma Legislation to safeguard patient access and boost off-patent medicines efficiency

Call to ‘Stop the Clock’ on UWWTD – Urgent reassessment needed to protect competitiveness and supply

Press statement on UWWTD Court Decision

Overview of the pilots in Europe testing the use of the electronic product information (ePI) for medicines

Parliament makes the Critical Medicines Act meaningful but significant risks to future access persist

Steffen Saltofte (Zentiva) named President of Medicines for Europe

The EU Biosimilar industry, which is central to competitiveness, needs Ambitious, Coherent, & Competition-Driven Biotech Policies